Furthermore, the vasorelaxant effect of ACPA on aortic rings from diabetic rats after eight weeks of diabetes induction was almost completely reversed when the rings were incubated with the CB1 antagonist AM281 30 min previous to the addition of ACPA (3.86 ± 1.78%; n = 5 rats). Here, CNR1 is linked to diabetes mellitus.